Search

everythinglearnresearchcommunity

for

Search:↓

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Mild oxidative stress can prevent hair loss from chemotherapy.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

New mutations in KRT83 and KRT86 are linked to the hair disorder monilethrix.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Single-cell transcriptomics helps improve animal health and productivity by studying gene expression in individual cells.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.